chr7-117627556-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PP2PP3_Moderate
The NM_000492.4(CFTR):c.3503A>G(p.Asp1168Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. D1168D) has been classified as Likely benign.
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Publications
- cystic fibrosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Orphanet
- congenital bilateral absence of vas deferensInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary chronic pancreatitisInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CFTR | NM_000492.4 | c.3503A>G | p.Asp1168Gly | missense_variant | Exon 22 of 27 | ENST00000003084.11 | NP_000483.3 | |
| CFTR-AS2 | NR_199597.1 | n.66-11216T>C | intron_variant | Intron 1 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000798 AC: 2AN: 250718 AF XY: 0.00000738 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461020Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726818 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74332 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
PP3, PM2, PM3_supporting -
- -
not specified Uncertain:1
Variant summary: CFTR c.3503A>G (p.Asp1168Gly) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 250718 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.3503A>G has been reported in the literature in the compound heterozygous state in an individual affected with a CFTR-Related Disease and in an individual with metabolic alkalosis, as well as in an infant with a CF-screening positive inconclusive diagnosis by newborn screening (e.g. Lucarelli_2015, Esposito_2020, Castaldo_2020). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 32784480, 33260873, 25910067). ClinVar contains an entry for this variant (Variation ID: 53763). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Cystic fibrosis Uncertain:1
The p.D1168G variant (also known as c.3503A>G), located in coding exon 22 of the CFTR gene, results from an A to G substitution at nucleotide position 3503. The aspartic acid at codon 1168 is replaced by glycine, an amino acid with similar properties. This variant has been reported in an individual with a CFTR-related disorder; however, clinical details were limited (Lucarelli M et al. Mol. Med., 2015 Apr;21:257-75). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at